2016 Rallying Survey: Data, Data, Data - Cure Parkinson's

Cure Parkinson's

25,478 members26,802 posts

2016 Rallying Survey: Data, Data, Data

CPT_Helen profile image
CPT_HelenPartner
3 Replies

This year we want to understand what information people with Parkinson's share and how that information can influence decision making in healthcare and research.

Your views are extremely important to us. We will use the information gathered from this survey to form the basis of the focused discussions at the "Rallying to the Challenge" meeting this September. The survey should take 15-20 minutes to complete.

If you would like to share your views, please click the link below to complete the survey.

surveymonkey.co.uk/r/2016Ra...

Written by
CPT_Helen profile image
CPT_Helen
Partner
To view profiles and participate in discussions please or .
3 Replies
laglag profile image
laglag

Is this just for the UK folks?

CPT_Helen profile image
CPT_HelenPartner in reply to laglag

Thanks so much. A survey for people living with people with Parkinson's will be posted early next week. And we would love to hear from you wherever you are in the world. Your views are very important. Many thanks. Helen

soup profile image
soup

Hi Helen, can we companions/partners/caregivers have a survey entry point please. My husband gathers information one way and I use social media and forums to add to the decision making.

We are both part of the information gathering and decision making team sitting on the patien't side of the consulting room.

You may also like...

Results of the recent survey

have spoken! Here are the results of the recent survey on which protocols members are using to...

Closing soon - Genetics and Parkinson's disease survey

Parkinson's Movement would be very grateful for your help in completing our survey that looks at...

Further Roche vaccine trial data

A Friend with Parkinson's Died Thursday, May 12, 2016.

A Friend with Parkinson's Died Thursday, May 12, 2016. She was only 63. We went to high school...

Bayer reports positive early data for Parkinson’s cell therapy